vs
Axsome Therapeutics, Inc.（AXSM）与Liberty Broadband Corp（LBRDA）财务数据对比。点击上方公司名可切换其他公司
Liberty Broadband Corp的季度营收约是Axsome Therapeutics, Inc.的1.4倍（$261.0M vs $191.2M），Axsome Therapeutics, Inc.同比增速更快（57.4% vs 6.1%），过去两年Axsome Therapeutics, Inc.的营收复合增速更高（48.1% vs 4.3%）
Jazz Pharmaceuticals是一家全球生物制药企业，专注于肿瘤学与神经科学领域的药物研发及商业化。公司2003年在美国加利福尼亚州成立，目前总部位于爱尔兰都柏林，业务覆盖全球多个核心市场。
本公司是一家覆盖英、荷、美三地的跨国电信企业，注册地为百慕大，在伦敦、阿姆斯特丹、丹佛设有总部，旗下拥有多家对应司法辖区的运营主体，其中英国主体为公开上市实体，2005年由自由媒体国际业务板块与UnitedGlobalCom合并成立。
AXSM vs LBRDA — 直观对比
营收规模更大
LBRDA
是对方的1.4倍
$191.2M
营收增速更快
AXSM
高出51.3%
6.1%
两年增速更快
AXSM
近两年复合增速
4.3%
损益表 — Q1 FY2026 vs Q2 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $191.2M | $261.0M |
| 净利润 | — | $383.0M |
| 毛利率 | — | — |
| 营业利润率 | -33.1% | 15.7% |
| 净利率 | — | 146.7% |
| 营收同比 | 57.4% | 6.1% |
| 净利润同比 | — | 96.4% |
| 每股收益（稀释后） | — | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AXSMLBRDA
| Q1 26 | $191.2M | — | ||
| Q4 25 | $196.0M | — | ||
| Q3 25 | $171.0M | — | ||
| Q2 25 | $150.0M | $261.0M | ||
| Q1 25 | $121.5M | $266.0M | ||
| Q4 24 | $118.8M | $263.0M | ||
| Q3 24 | $104.8M | $262.0M | ||
| Q2 24 | $87.2M | $246.0M |
净利润AXSMLBRDA
| Q1 26 | — | — | ||
| Q4 25 | $-28.6M | — | ||
| Q3 25 | $-47.2M | — | ||
| Q2 25 | $-48.0M | $383.0M | ||
| Q1 25 | $-59.4M | $268.0M | ||
| Q4 24 | $-74.9M | $291.0M | ||
| Q3 24 | $-64.6M | $142.0M | ||
| Q2 24 | $-79.3M | $195.0M |
营业利润率AXSMLBRDA
| Q1 26 | -33.1% | — | ||
| Q4 25 | -13.8% | — | ||
| Q3 25 | -27.0% | — | ||
| Q2 25 | -24.5% | 15.7% | ||
| Q1 25 | -46.9% | 16.2% | ||
| Q4 24 | -61.1% | 4.9% | ||
| Q3 24 | -59.8% | 11.5% | ||
| Q2 24 | -89.5% | 8.5% |
净利率AXSMLBRDA
| Q1 26 | — | — | ||
| Q4 25 | -14.6% | — | ||
| Q3 25 | -27.6% | — | ||
| Q2 25 | -32.0% | 146.7% | ||
| Q1 25 | -48.9% | 100.8% | ||
| Q4 24 | -63.1% | 110.6% | ||
| Q3 24 | -61.7% | 54.2% | ||
| Q2 24 | -91.0% | 79.3% |
每股收益（稀释后）AXSMLBRDA
| Q1 26 | — | — | ||
| Q4 25 | $-0.55 | — | ||
| Q3 25 | $-0.94 | — | ||
| Q2 25 | $-0.97 | $2.68 | ||
| Q1 25 | $-1.22 | $1.87 | ||
| Q4 24 | $-1.54 | $2.04 | ||
| Q3 24 | $-1.34 | $0.99 | ||
| Q2 24 | $-1.67 | $1.36 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $305.1M | $180.0M |
| 总债务越低越好 | $70.0M | $3.1B |
| 股东权益账面价值 | — | $10.4B |
| 总资产 | $713.6M | $16.6B |
| 负债/权益比越低杠杆越低 | — | 0.30× |
8季度趋势，按日历期对齐
现金及短期投资AXSMLBRDA
| Q1 26 | $305.1M | — | ||
| Q4 25 | $322.9M | — | ||
| Q3 25 | $325.3M | — | ||
| Q2 25 | $303.0M | $180.0M | ||
| Q1 25 | $300.9M | $226.0M | ||
| Q4 24 | $315.4M | $163.0M | ||
| Q3 24 | $327.3M | $168.0M | ||
| Q2 24 | $315.7M | $73.0M |
总债务AXSMLBRDA
| Q1 26 | $70.0M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | $3.1B | ||
| Q1 25 | — | $3.8B | ||
| Q4 24 | — | $3.8B | ||
| Q3 24 | — | $3.7B | ||
| Q2 24 | — | $3.6B |
股东权益AXSMLBRDA
| Q1 26 | — | — | ||
| Q4 25 | $88.3M | — | ||
| Q3 25 | $73.7M | — | ||
| Q2 25 | $73.1M | $10.4B | ||
| Q1 25 | $53.2M | $10.1B | ||
| Q4 24 | $57.0M | $9.8B | ||
| Q3 24 | $92.9M | $9.5B | ||
| Q2 24 | $102.9M | $9.3B |
总资产AXSMLBRDA
| Q1 26 | $713.6M | — | ||
| Q4 25 | $689.8M | — | ||
| Q3 25 | $669.3M | — | ||
| Q2 25 | $639.8M | $16.6B | ||
| Q1 25 | $596.7M | $17.0B | ||
| Q4 24 | $568.5M | $16.7B | ||
| Q3 24 | $561.5M | $16.3B | ||
| Q2 24 | $548.2M | $16.0B |
负债/权益比AXSMLBRDA
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.30× | ||
| Q1 25 | — | 0.38× | ||
| Q4 24 | — | 0.38× | ||
| Q3 24 | — | 0.39× | ||
| Q2 24 | — | 0.39× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $91.0M |
| 自由现金流经营现金流 - 资本支出 | — | $37.0M |
| 自由现金流率自由现金流/营收 | — | 14.2% |
| 资本支出强度资本支出/营收 | — | 20.7% |
| 现金转化率经营现金流/净利润 | — | 0.24× |
| 过去12个月自由现金流最近4个季度 | — | $-49.0M |
8季度趋势，按日历期对齐
经营现金流AXSMLBRDA
| Q1 26 | — | — | ||
| Q4 25 | $-18.7M | — | ||
| Q3 25 | $1.0M | — | ||
| Q2 25 | $-32.4M | $91.0M | ||
| Q1 25 | $-43.4M | $78.0M | ||
| Q4 24 | $-26.2M | $1.0M | ||
| Q3 24 | $-18.6M | $24.0M | ||
| Q2 24 | $-30.1M | $27.0M |
自由现金流AXSMLBRDA
| Q1 26 | — | — | ||
| Q4 25 | $-18.7M | — | ||
| Q3 25 | $988.0K | — | ||
| Q2 25 | $-32.4M | $37.0M | ||
| Q1 25 | $-43.7M | $13.0M | ||
| Q4 24 | $-26.2M | $-63.0M | ||
| Q3 24 | $-18.7M | $-36.0M | ||
| Q2 24 | $-30.2M | $-35.0M |
自由现金流率AXSMLBRDA
| Q1 26 | — | — | ||
| Q4 25 | -9.6% | — | ||
| Q3 25 | 0.6% | — | ||
| Q2 25 | -21.6% | 14.2% | ||
| Q1 25 | -36.0% | 4.9% | ||
| Q4 24 | -22.1% | -24.0% | ||
| Q3 24 | -17.9% | -13.7% | ||
| Q2 24 | -34.6% | -14.2% |
资本支出强度AXSMLBRDA
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | — | ||
| Q3 25 | 0.0% | — | ||
| Q2 25 | 0.0% | 20.7% | ||
| Q1 25 | 0.3% | 24.4% | ||
| Q4 24 | 0.0% | 24.3% | ||
| Q3 24 | 0.1% | 22.9% | ||
| Q2 24 | 0.1% | 25.2% |
现金转化率AXSMLBRDA
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | 0.24× | ||
| Q1 25 | — | 0.29× | ||
| Q4 24 | — | 0.00× | ||
| Q3 24 | — | 0.17× | ||
| Q2 24 | — | 0.14× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AXSM
| Product sales, net | $189.4M | 99% |
| Royalty revenue and milestone revenue | $1.8M | 1% |
LBRDA
暂无分部数据
